Safety and efficacy of increased ipilimumab dosage in metastatic melanoma
Highlights in the development of new therapies and novel drugs in treating melanoma
What is the future of melanoma immunotherapy
CABOSUN trial of cabozantinib - could it change how we treat frontline RCC?
Melanoma Patient Network Europe sessions at ESMO 2016